ANAVEX LIFE SCIENCES CORP. (AVXL) is a publicly traded company in the Unknown sector. Across all available filings, 9 corporate insiders have executed 94 transactions totaling $18.0M, demonstrating a bearish sentiment with -$17.1M in net insider flow. The most recent transaction on Jan 6, 2026 involved a transaction of 12,500 shares valued at $0.
No significant insider buying has been recorded for AVXL in the recent period.
No significant insider selling has been recorded for AVXL in the recent period.
Based on recent SEC filings, insider sentiment for AVXL is bearish with an Insider Alignment Score of 3/100 and a net flow of -$17.1M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at ANAVEX LIFE SCIENCES CORP. (AVXL) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 9 insiders are actively trading AVXL stock, having executed 94 transactions in the past 90 days. The most active insider is Christopher U. Missling (Executive), who has made 49 transactions totaling $7.2M.
Get notified when executives and directors at AVXL file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 6, 2026 | Boenisch Sandra | PFO & Treasurer | Award | 12,500 | $N/A | $0 | |
| Jan 6, 2026 | U. Missling Christopher | Executive | Award | 125,000 | $N/A | $0 | |
| Sep 11, 2025 | U. Missling Christopher | Executive | Payment | 145,048 | $9.58 | $1.4M | Large |
| Sep 11, 2025 | U. Missling Christopher | Executive | Option Exercise | 187,500 | $5.04 | $945.0K | Large |
| Jun 14, 2024 | D.o. Donhauser Peter | Executive | Purchase | 2,835 | $3.64 | $10.3K | |
| May 15, 2024 | Thomas Steffen | Executive | Purchase | 5,000 | $4.52 | $22.6K | |
| Mar 28, 2024 | U. Missling Christopher | Executive | Option Exercise | 73,380 | $1.32 | $96.9K | |
| Mar 28, 2024 | U. Missling Christopher | Executive | Sale | 73,380 | $5.11 | $375.0K | |
| Jun 29, 2023 | U. Missling Christopher | Executive | Option Exercise | 232,000 | $1.60 | $371.2K | |
| Jun 28, 2023 | U. Missling Christopher | Executive | Option Exercise | 268,000 | $1.60 | $428.8K | |
| Jun 28, 2023 | U. Missling Christopher | Executive | Sale | 268,000 | $7.98 | $2.1M | Large |
| May 25, 2022 | Skarpelos Athanasios | Executive | Sale | 50,000 | $9.06 | $453.0K | |
| May 25, 2022 | Skarpelos Athanasios | Executive | Option Exercise | 50,000 | $0.92 | $46.0K | |
| Jun 29, 2021 | Boenisch Sandra | Executive | Option Exercise | 25,000 | $5.68 | $142.0K | |
| Jun 29, 2021 | Boenisch Sandra | Executive | Option Exercise | 106,696 | $3.28 | $350.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 22 | $17.5M | 77.0% |
Exercise(M) | 19 | $3.4M | 14.9% |
Payment(F) | 1 | $1.4M | 6.1% |
Purchase(P) | 45 | $451.8K | 2.0% |
Other(J) | 2 | $10.0K | 0.0% |
Award(A) | 2 | $0 | 0.0% |
Gift(G) | 3 | $0 | 0.0% |
Insider selling pressure at ANAVEX LIFE SCIENCES CORP. has increased, with 9 insiders executing 94 transactions across all time. Total sales of $17.5M significantly outpace purchases of $451.8K, resulting in a net outflow of $17.1M. This selling activity appears largely discretionary, which may warrant closer attention from investors.